FREQUENCY OF HEPATITIS C VIRUS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AT TERTIARY CARE SETTINGS

Main Article Content

Abdul Haque Khan
Atif Sitwat Hayat
Syed Mohammad Iqbal Shah
Shoaib Manzoor Memon

Abstract

OBJECTIVE: To determine the frequency of hepatitis C virus infection in chronic obstructive pulmonary disease (COPD) at a tertiary care settings.

METHODS: This cross-sectional study was conducted at Liaquat University of Medical & Health Sciences Jamshoro form 10th April to 10th October 2013. Patients of either sex and ages form 30-65 years having COPD of at least three years who gave informed and written consent were enrolled. Blood samples of COPD patients were sent to hospital laboratory for detection of HCV antibodies via second generation ELISA. Patients having asthma, chronic liver disease, history of blood transfusion and surgical procedure in previous six months were excluded.

RESULTS: Mean age of enrolled participants was 44.41±3.5 years, ranging from 30-65 years. Male and female ratio was 1.8:1. Mean duration of illness was 3.55±0.222 years. Frequency of hepatitis C virus positivity in patients of COPD was 9(8.4%). Of 59 patients of 45 years of age were positive for HCV (p=0.153). Of 69 male patients, 3(4.3%) were positive for HCV compared to 6/38(15.8%) female patients (p=0.05). Comparing analysis of HCV positivity with regard to duration of COPD, 1/53 (1.9%) patients with duration of illness up-to 3.5 years was positive for HCV compared to 8/58 (14.8%) patients with duration of illness of >3.5 years (p=0.0017).

CONCLUSION: Frequency of hepatitis C virus positivity in COPD patients was 8.4%. Earlier and prompts treatment should be initiated to minimize HCV related morbidity.

KEY WORDS: Hepatitis C (MeSH), Chronic Obstructive Pulmonary Disease (MeSH), Chronic Obstructive Airway Disease (MeSH)

Article Details

How to Cite
Khan, A., A. Hayat, S. Shah, and S. Memon. “FREQUENCY OF HEPATITIS C VIRUS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AT TERTIARY CARE SETTINGS”. KHYBER MEDICAL UNIVERSITY JOURNAL, Vol. 7, no. 3, Sept. 2015, https://www.kmuj.kmu.edu.pk/article/view/14011.
Section
Original Articles
Author Biography

Abdul Haque Khan, liaquat university of medical and health sciences jamshoro,hyderabad

FACULTY OF MEDICINE LUMHS JAMSORO HYD; SINDH.

References

REFERENCE:
1. Feghali-Bostwick CA, Gadgil AS, Otterbein
LE, Pilewski JM, Stoner MW, Csizmadia
E. Autoantibodies in patients with chronic
obstructive pulmonary disease. Am J respire
Crit Care Med 2008;177(2): 156-63.
2. Casanova C, de Torres JP, Navarro J,
Aguirre-Jaíme A, Toledo P, et al. Microalbuminuria
and hypoxemia in patients with
chronic obstructive pulmonary disease.
Am J Respir Crit Care Med 2010; 182:
1004-10.
3. Tanveer A, Batool K, Qureshi AW: Prevalence
of hepatitis B and c in university
of the Punjab, Quaid-e-azam campus,
Lahore. J Agric Biol Sci 2008, 3:30-2.
4. Alianejad R, Ghanei M. Hepatitis C and
pulmonary fibrosis. Hepa Mon 201;
11(2): 7-3.
5. Yearsley MM, Diaz PT, Knoell D, Nuovo
GJ. Correlation of HIV-1 detection and
histology in AIDS-associated emphysema.
Diagn Mol Pathol 2005; 14: 48-52.
6. Retamales I elliott WM Meshwi B. Amplification
of inflammation in emphysema and
its association with latent adenoviral infection.
Am J ResirCrit Car Med 200;164(3):
469-73.
7. Kanazawa, H, Hirata, K, Yoshikawa, J.
Accelerated decline of lung function in
COPD patients with chronic hepatitis
C virus infection: a preliminary study
based on small numbers of patients.Chest
2003;123,596-9.
8. Silva DR, Stifft J, Cheinquer H, Knorst MM.
Prevalence of hepatitis C virus infection
in patients with COPD. Prevalence of
hepatitis C virus infection in patients with
COPD. 2010;138(2):167-73.
9. Serpil Erol, Leyla Sağslam, Ahmet Ozbek,
Ayten Kadanati,. Hepatitis C Virus Infection
and Chronic Obstructive Pulmonary
Disease. Hepatitis monthly 2009: 9();
39-44.
10. Zignego AL, Ferri C, Pileri SA, Chaini P,
Bianchi FB. Extrahepatic manifestation of
Hepatitis C Virus infection: a general overview
and guidelines for clinical approach.
Dig Liver Dis 2007; 39(): 2-17.
11. Butt AA, Khan UA, McGinnis KA, Skanderson
M, KentKwoh C. Co-morbid medical
and pychiatric illness and substance abuse
in HCV-infected and uninfected veterans.
J Viral Hepat 2007;14(12): 890-6.
12. Erturk A, Tokgonul AN, Capan N, Erturk
H, Dursun AB, Bozkaya H et al. Pulmonary
alterations in patients with chronic HCV
infection. Dig Liver Dig Dis 2006;38(9):
673-6.
13. Okuntan O, Kartaloglu Z, Ilvan A, Kutlu
A, Bozkanat E, Sili E, et al. Values of
high-resolution computed tomography
and pulmonary function tests in managements
of patients with chronic hepatitis
C virus infection. World J Gastroenterolv2004;
10(3): 28-4.
14. Vincken W, Van Noord JA, Greefhorst
AP, Bantje TA, Kesten S, Korducki L, et al.
Improved health outcomes in patients with
COPD during 1 yr’s treatment with tiotropium.
Eur Respir J 2002;19(2):209-16.
15. Morissette MC, Vachon-Beaudoin G, Parent
J, Chakir J, Milot J. Increased p53 level,
Bax/Bcl-x(L) ratio, and TRAIL receptor
expression in human emphysema. Am J
Respir Crit Care Med 2008;178(3):240-7.